Tianyanxin Sun (Tian)

Tianyanxin (Tian) Sun, Ph.D., currently serves as a Medical Writer at BluPrint Oncology since March 2022. Prior to this role, Tian was a Postdoctoral Scholar at Stanford University School of Medicine from October 2019 to December 2021, leading projects on preeclampsia pathogenesis and genetic variants associated with hypertensive disorders in diverse populations. Before Stanford, Tian held the position of Postdoctoral Scientist at Cedars-Sinai from May 2016 to September 2019, focusing on maternal-fetal interactions and their clinical implications for fertility and health. Earlier research experience includes a doctoral program at Penn State University, where Tian investigated the Hippo signaling pathway in ovarian functions and served as a Teaching Assistant. Educational qualifications include a Ph.D. in Reproductive Physiology from Penn State University and a Bachelor's Degree in Animal Sciences from China Agricultural University.